Law360 | The Defining Pandemic Moments for Health and Life Sci Attys

Cathy Burgess, partner in Alston & Bird’s Health Care Group and leader of the firm’s FDA Compliance & Enforcement Team, has been recognized by The National Law Journal in its third annual list of professionals identified as agents of change in health care and life sciences law.

Alston & Bird has formed a working group to advise clients on the business and legal implications of the COVID-19 coronavirus.

Our FDA/Food, Drug & Device and Health Care teams discuss new guidance from the Food and Drug Administration (FDA) on federal notification requirements for medical device manufacturing shortages during public health emergencies (PHEs). 

This week, bipartisan members of the House and Senate introduced new PBM reform legislation, while ASTP/ONC released its Trusted Exchange Framework and Common Agreement (TEFCA) final rule.

This week, Republicans won a slim majority in the House of Representatives, and CMS released a report on rural health innovation following the 2024 Rural Health Hackathon.